The significance of bone scan abnormalities in patients with primary osteogenic sarcoma

S. M. Keller, R. C. Rosenbaum, S. A. Rosenberg

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The radionuclide bone scans and medical records of 62 patients with osteogenic sarcoma were reviewed to determine the significance of abnormalities demonstrated by the initial scintigraph at sites other than the primary lesion. 94% (58/62) of patients had abnormally increased tracer uptake at sites other than the primary tumor location. Eighty percent (49/62) of patients had abnormal bone scans at the ipsilateral proximal weight bearing joints. Only two of these patients later demonstrated metastatic tumor. Sixty-one percent (38/62) of patients had abnormal bone scans at joints distal to the primary tumor and none were due to tumor. Five patients ultimately developed osseous metastases at sites that were normal in the original scan. The majority of radionuclide bone scan abnormalities occurring at the time of diagnosis of osteogenic sarcoma at locations distant from the primary tumor site do not represent metastatic disease.

Original languageEnglish (US)
Pages (from-to)122-129
Number of pages8
JournalJournal of Surgical Oncology
Volume26
Issue number2
StatePublished - 1984
Externally publishedYes

Fingerprint

Osteosarcoma
Bone and Bones
Neoplasms
Radioisotopes
Joints
Weight-Bearing
Medical Records
Neoplasm Metastasis

ASJC Scopus subject areas

  • Oncology
  • Surgery

Cite this

Keller, S. M., Rosenbaum, R. C., & Rosenberg, S. A. (1984). The significance of bone scan abnormalities in patients with primary osteogenic sarcoma. Journal of Surgical Oncology, 26(2), 122-129.

The significance of bone scan abnormalities in patients with primary osteogenic sarcoma. / Keller, S. M.; Rosenbaum, R. C.; Rosenberg, S. A.

In: Journal of Surgical Oncology, Vol. 26, No. 2, 1984, p. 122-129.

Research output: Contribution to journalArticle

Keller, SM, Rosenbaum, RC & Rosenberg, SA 1984, 'The significance of bone scan abnormalities in patients with primary osteogenic sarcoma', Journal of Surgical Oncology, vol. 26, no. 2, pp. 122-129.
Keller, S. M. ; Rosenbaum, R. C. ; Rosenberg, S. A. / The significance of bone scan abnormalities in patients with primary osteogenic sarcoma. In: Journal of Surgical Oncology. 1984 ; Vol. 26, No. 2. pp. 122-129.
@article{2eb4cda738224273bcb89fb505aac5a4,
title = "The significance of bone scan abnormalities in patients with primary osteogenic sarcoma",
abstract = "The radionuclide bone scans and medical records of 62 patients with osteogenic sarcoma were reviewed to determine the significance of abnormalities demonstrated by the initial scintigraph at sites other than the primary lesion. 94{\%} (58/62) of patients had abnormally increased tracer uptake at sites other than the primary tumor location. Eighty percent (49/62) of patients had abnormal bone scans at the ipsilateral proximal weight bearing joints. Only two of these patients later demonstrated metastatic tumor. Sixty-one percent (38/62) of patients had abnormal bone scans at joints distal to the primary tumor and none were due to tumor. Five patients ultimately developed osseous metastases at sites that were normal in the original scan. The majority of radionuclide bone scan abnormalities occurring at the time of diagnosis of osteogenic sarcoma at locations distant from the primary tumor site do not represent metastatic disease.",
author = "Keller, {S. M.} and Rosenbaum, {R. C.} and Rosenberg, {S. A.}",
year = "1984",
language = "English (US)",
volume = "26",
pages = "122--129",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - The significance of bone scan abnormalities in patients with primary osteogenic sarcoma

AU - Keller, S. M.

AU - Rosenbaum, R. C.

AU - Rosenberg, S. A.

PY - 1984

Y1 - 1984

N2 - The radionuclide bone scans and medical records of 62 patients with osteogenic sarcoma were reviewed to determine the significance of abnormalities demonstrated by the initial scintigraph at sites other than the primary lesion. 94% (58/62) of patients had abnormally increased tracer uptake at sites other than the primary tumor location. Eighty percent (49/62) of patients had abnormal bone scans at the ipsilateral proximal weight bearing joints. Only two of these patients later demonstrated metastatic tumor. Sixty-one percent (38/62) of patients had abnormal bone scans at joints distal to the primary tumor and none were due to tumor. Five patients ultimately developed osseous metastases at sites that were normal in the original scan. The majority of radionuclide bone scan abnormalities occurring at the time of diagnosis of osteogenic sarcoma at locations distant from the primary tumor site do not represent metastatic disease.

AB - The radionuclide bone scans and medical records of 62 patients with osteogenic sarcoma were reviewed to determine the significance of abnormalities demonstrated by the initial scintigraph at sites other than the primary lesion. 94% (58/62) of patients had abnormally increased tracer uptake at sites other than the primary tumor location. Eighty percent (49/62) of patients had abnormal bone scans at the ipsilateral proximal weight bearing joints. Only two of these patients later demonstrated metastatic tumor. Sixty-one percent (38/62) of patients had abnormal bone scans at joints distal to the primary tumor and none were due to tumor. Five patients ultimately developed osseous metastases at sites that were normal in the original scan. The majority of radionuclide bone scan abnormalities occurring at the time of diagnosis of osteogenic sarcoma at locations distant from the primary tumor site do not represent metastatic disease.

UR - http://www.scopus.com/inward/record.url?scp=0021255230&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021255230&partnerID=8YFLogxK

M3 - Article

C2 - 6588278

AN - SCOPUS:0021255230

VL - 26

SP - 122

EP - 129

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 2

ER -